基他胺代谢物的NMDAR抑制独立的抗抑郁作用
Panos Zanos1, Ruin Moaddel2, Patrick J Morris3
1Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
胺的抗抑郁作用依赖于其代谢物氨基胺 (HNK). 通过AMPA受体激活,而不是NMDAR抑制, (2R,6R) -HNK反体表现出抗抑郁作用,并且缺乏胺.
科学领域:
- 神经科学
- 药理学
- 精神病学
背景情况:
- 大型抑郁症 (MDD) 影响全球人口的16%.
- 目前的单氨基抗抑郁药对许多患者起作用缓慢且有效性有限.
- (R,S) - 胺提供快速抗抑郁作用但有副作用.
研究的目的:
- 研究 (R,S) - 胺代谢对其抗抑郁作用的作用.
- 确定负责抗抑郁作用的氨基基胺 (HNK) 的特定反体.
- 阐明HNK抗抑郁作用的作用机制.
主要方法:
- 研究了 (R,S) - 胺转化为氨基胺 (HNK) 的代谢.
- 给小鼠使用 (2R,6R) -HNK反体来评估行为,脑电图,电生理和细胞效应.
- 研究了N-甲基-D-阿斯巴达酸受体 (NMDAR) 和α-氨基-3-基-5-甲基-4-异酸受体 (AMPAR) 的参与.
主要成果:
- (R,S) - 胺对HNK的代谢对于其抗抑郁性质至关重要.
- 在小鼠中, (2R,6R) - HNK反体表现出抗抑郁作用.
- (2R,6R) - HNK的抗抑郁作用独立于NMDAR抑制,并涉及AMPAR激活.
- (2R,6R) -HNK缺乏与胺相关的副作用.
结论:
- (R,S) - 胺的抗抑郁作用由其代谢物HNK介导.
- 该 (2R,6R) -HNK反体代表了抑郁症的新疗法标.
- 这一发现为开发下一代抗抑郁药物开辟了道路,
更多相关视频
05:42Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
07:56A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Parenteral Anesthetics: Overview
Drugs Affecting Neurotransmitter Release or Uptake
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
